Additionally, mutations in epigenetic modifier genes such as TET2, ASXL1, DNMT3A, and EZH2 occur frequently in MPN cases, with reported frequencies ranging from 1% to 30% [20]. This evidence concerns the gene TET2 and myeloproliferative disorder.